These results show that G-exo-stimulated DC vaccination can induce more effective protection with a greater increase in the number of tumor-reactive multifunctional CD4+ and CD8+ T cells in tumor-bearing mice than in N-exo-stimulated DC vaccination. This evidence concerns the gene CD4 and neoplasm.